Lange Jenny, Wood-Kaczmar Alison, Ali Aneesa, Farag Sahar, Ghosh Rhia, Parker Jennifer, Casey Caroline, Uno Yumiko, Kunugi Akiyoshi, Ferretti Patrizia, Andre Ralph, Tabrizi Sarah J
Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Neuroscience Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
Front Cell Neurosci. 2021 Sep 29;15:742763. doi: 10.3389/fncel.2021.742763. eCollection 2021.
Huntington's disease (HD) is an inherited neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin gene (). Disease progression is characterized by the loss of vulnerable neuronal populations within the striatum. A consistent phenotype across HD models is disruption of nucleocytoplasmic transport and nuclear pore complex (NPC) function. Here we demonstrate that high content imaging is a suitable method for detecting mislocalization of lamin-B1, RAN and RANGAP1 in striatal neuronal cultures thus allowing a robust, unbiased, highly powered approach to assay nuclear pore deficits. Furthermore, nuclear pore deficits extended to the selectively vulnerable DARPP32 + subpopulation neurons, but not to astrocytes. Striatal neuron cultures are further affected by changes in gene and protein expression of RAN, RANGAP1 and lamin-B1. Lowering total HTT using targeted anti-sense oligonucleotides partially restored gene expression, as well as subtly reducing mislocalization of proteins involved in nucleocytoplasmic transport. This suggests that mislocalization of RAN, RANGAP1 and lamin-B1 cannot be normalized by simply reducing expression of CAG-expanded HTT in the absence of healthy HTT protein.
亨廷顿舞蹈症(HD)是一种遗传性神经退行性疾病,由亨廷顿基因中的CAG重复序列扩增引起。疾病进展的特征是纹状体内易损神经元群体的丧失。HD模型的一个一致表型是核质运输和核孔复合体(NPC)功能的破坏。在这里,我们证明高内涵成像适合检测纹状体神经元培养物中核纤层蛋白B1、RAN和RANGAP1的定位错误,从而提供一种强大、无偏倚、高效的方法来检测核孔缺陷。此外,核孔缺陷扩展到选择性易损的DARPP32 + 亚群神经元,但未扩展到星形胶质细胞。纹状体神经元培养物进一步受到RAN、RANGAP1和核纤层蛋白B1基因和蛋白表达变化的影响。使用靶向反义寡核苷酸降低总亨廷顿蛋白(HTT)可部分恢复基因表达,并略微减少参与核质运输的蛋白的定位错误。这表明,在缺乏健康HTT蛋白的情况下,简单地降低CAG扩增的HTT表达并不能使RAN、RANGAP1和核纤层蛋白B1的定位错误恢复正常。